Literature DB >> 23735144

Hemodialysis patients born with a low birth weight should have a different time course of kidney diseases than those born with a normal birth weight.

Toshiyuki Imasawa1, Naoyuki Fukuda, Satoru Hirose, Naohiko Kato, Shinya Suganuma, Ryo Yamamoto, Hiroaki Kimura, Moritoshi Kadomura, Motonobu Nishimura, Mitsuhiro Yoshimura, Satoshi Ikei.   

Abstract

Low birth weight (LBW) is thought to be one of the risk factors for the progression of kidney diseases. This study hypothesized that the onset age of kidney disease, the rate of progression of kidney disease, or the age at the time of hemodialysis (HD) induction among HD patients that were born with LBW is different from those without a history of LBW. A questionnaire survey in nine dialysis units in Japan was performed and 427 answer sheets were collected. There were statistically significant differences in the present age, the age of kidney disease onset, and the age of HD induction between LBW group and normal birth weight group (NBW). An analysis limited to participants whose underlying disease was diabetic nephropathy revealed that the duration from the onset of nephropathy to HD induction was much shorter in HD patients with a history of LBW than those with a NBW history. In addition, the Pearson's correlation coefficient between the birth weight and the period from onset of diabetic nephropathy to HD induction was 0.283. Although these results might partly support the primary hypothesis, the necessity to perform other clinical studies is also emphasized.
© 2013 The Authors. Therapeutic Apheresis and Dialysis © 2013 International Society for Apheresis.

Entities:  

Mesh:

Year:  2013        PMID: 23735144     DOI: 10.1111/1744-9987.12002

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  1 in total

1.  Pathological similarities between low birth weight-related nephropathy and nephropathy associated with mitochondrial cytopathy.

Authors:  Toshiyuki Imasawa; Masashi Tanaka; Naoki Maruyama; Takehiko Kawaguchi; Yutaka Yamaguchi; Rodrigue Rossignol; Hiroshi Kitamura; Motonobu Nishimura
Journal:  Diagn Pathol       Date:  2014-09-30       Impact factor: 2.644

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.